Histopathologic characteristics of scleromyxedema: A study of a series of 34 cases
- PMID: 26897387
- DOI: 10.1016/j.jaad.2015.12.021
Histopathologic characteristics of scleromyxedema: A study of a series of 34 cases
Abstract
Background: Few histologic studies describe the histopathologic aspects of scleromyxedema.
Objective: We sought to describe the histopathologic and immunohistochemical features of scleromyxedema in a large series of patients.
Methods: We studied all the cases with scleromyxedema diagnosed between 2000 and 2014 at participating centers. Sections with hematoxylin-eosin and special stains were examined. Immunohistochemistry for CD3, CD4, CD8, CD20, CD68, and factor XIIIa was performed in 10 cases.
Results: A total of 44 skin biopsy specimens from 34 patients were reviewed. Two different histopathologic patterns were observed: the classic microscopic triad (dermal mucin deposition, fibroblast proliferation, fibrosis) was identified in 34 specimens, whereas an interstitial granuloma annulare-like pattern was found in 10 specimens. A superficial perivascular infiltrate with T lymphocytes was found in all specimens whereas an interstitial proliferation of CD68(+) epithelioid cells was identified in the 10 specimens with an interstitial granuloma annulare-like pattern. Elastic fibers were largely lost, explaining the redundant folds of the disease.
Limitations: This was a retrospective study.
Conclusions: Scleromyxedema shows 2 histopathologic patterns, including the classic type with the microscopic triad of mucin, fibroblast proliferation and fibrosis, and an interstitial granuloma annulare-like pattern. Recognition of these histologic presentations expands the spectrum of scleromyxedema and highlights the difficulty in diagnosing this disabling condition in the absence of a clinicopathological correlation.
Keywords: fibromucinous disorder; histopathology; immunohistochemistry; interstitial granulomatous dermatitis; lichen myxedematosus; scleromyxedema.
Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Scleromyxedema with an interstitial granulomatous-like pattern: a rare histologic variant mimicking granuloma annulare.J Cutan Pathol. 2010 Oct;37(10):1084-7. doi: 10.1111/j.1600-0560.2009.01386.x. Epub 2009 Jul 22. J Cutan Pathol. 2010. PMID: 19638067
-
Unusual granulomatous variant of scleromyxedema.J Am Acad Dermatol. 2008 Aug;59(2):346-9. doi: 10.1016/j.jaad.2008.04.017. Epub 2008 May 15. J Am Acad Dermatol. 2008. PMID: 18485525 Review.
-
A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma.Am J Clin Pathol. 2006 Nov;126(5):805-14. doi: 10.1309/Y8KD-32QG-RYFN-1XQX. Am J Clin Pathol. 2006. PMID: 17050078
-
Frequency of cutis laxa-like clinical features and elastolysis in scleromyxedema: a retrospective clinicopathologic study of 19 patients with scleromyxedema.J Cutan Pathol. 2016 Mar;43(3):246-51. doi: 10.1111/cup.12657. Epub 2016 Feb 4. J Cutan Pathol. 2016. PMID: 26676919
-
Investigating the histopathological findings and immunolocalization of rickettsialpox infection in skin biopsies: A case series and review of the literature.J Cutan Pathol. 2020 May;47(5):451-458. doi: 10.1111/cup.13649. Epub 2020 Feb 3. J Cutan Pathol. 2020. PMID: 31955452 Review.
Cited by
-
Improvement of plaquelike cutaneous mucinosis after intravenous immunoglobulins treatment.JAAD Case Rep. 2020 Jun 15;6(8):710-712. doi: 10.1016/j.jdcr.2020.06.015. eCollection 2020 Aug. JAAD Case Rep. 2020. PMID: 32715057 Free PMC article. No abstract available.
-
New insights on scleromyxedema.J Scleroderma Relat Disord. 2019 Jun;4(2):118-126. doi: 10.1177/2397198318824929. Epub 2019 Jan 29. J Scleroderma Relat Disord. 2019. PMID: 35382389 Free PMC article. Review.
-
Monoclonal gammopathies of clinical significance.Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):380-388. doi: 10.1182/hematology.2020000122. Hematology Am Soc Hematol Educ Program. 2020. PMID: 33275738 Free PMC article.
-
Clinical Characteristics and Treatment Outcomes of Scleromyxedema: A 10-Year Retrospective Survey.Case Rep Dermatol. 2022 Jun 27;14(2):178-183. doi: 10.1159/000525211. eCollection 2022 May-Aug. Case Rep Dermatol. 2022. PMID: 35950147 Free PMC article.
-
Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.Clin Rev Allergy Immunol. 2017 Dec;53(3):306-336. doi: 10.1007/s12016-017-8625-4. Clin Rev Allergy Immunol. 2017. PMID: 28712039 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials